ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted approval for two gene therapies aimed...
New Facility to Drive Growth and Employment for the City of Independence
Independence Premium Foods Announces Ownership of Former Pet Food Production Facility Independence Premium Foods (IPF) is thrilled to announce that it will assume ownership of...
Fragrance Creators Association Congratulates Dr. Namandjé Bumpus on Her Promotion to Principal Deputy Commissioner at FDA
Today, the Food and Drug Administration (FDA) promoted Dr. Namandjé Bumpus, Ph.D., to Principal Deputy Commissioner. Farah K. Ahmed, President and CEO of Fragrance Creators Association...
Lactiga Receives FDA ‘Rare Pediatric Disease’ Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable Immunodeficiency Disease
Lactiga US, Inc., a visionary biotechnology company unlocking the therapeutic value of human milk antibodies, proudly announced today that the US Food and Drug Administration...
MMJ Prepares DEA Marijuana Lawsuit
FDA Sanctioned Marijuana Clinical Trials Researcher's Suit Moves To DC Appellate Court, The DEA is the Epitome Of IneptitudeWESTERLY, RI / ACCESSWIRE / August 2...
FDA Denies Substance Misuse ‘Risk Score’ Citizen Petition
Agency relies on broad procedural interpretation, says evaluation ongoingWASHINGTON, DC / ACCESSWIRE / August 1, 2023 / The Food and Drug Administration (FDA) has denied...
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’
Neobiosis, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of...
Over 1,200 Food Safety Professionals Gather In Person and Another 1,500 Online for The 25th Annual Food Safety Summit
ROSEMONT, IL / ACCESSWIRE / May 18, 2023 / The 2023 Food Safety Summit, held from May 8-11, was a highly anticipated event that brought...
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
- Dermata raised $5 million gross proceeds from a public offering in March 2023 -- Dermata submitted an End of Phase 2 meeting package to...
C. Light Receives Clearance for Retinal Eye Movement Monitor, Retitrack(TM)
Revolutionary medical device is first retinal eye-movement monitor for non-invasive, objective clinical assessmentsBOSTON, MA / ACCESSWIRE / May 11, 2023 / C. Light Technologies, Inc.,...